Lanzol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lanzol

Quick Facts

Property Description
Active ingredient Lansoprazole
Form Gastro-resistant capsule / Delayed-release capsule
Pharmacological class Proton Pump Inhibitor (PPI)
Common use Reduction of gastric acid secretion
Origin Synthetic (Substituted benzimidazole)

What Type of Medicine is Lanzol?

Lanzol is a medication whose identity is defined by its active chemical component, lansoprazole. It belongs to the high-level pharmacological class of Proton Pump Inhibitors (PPIs), positioning it as an antisecretory medicinal product used to manage excessive acid production. Lansoprazole is a synthetic drug that is chemically classified as a substituted benzimidazole derivative. The effectiveness of this class in achieving sustained acid suppression places it among the standard treatments for acid-related issues.


Composition and Physical Form of Lanzol

The core composition of Lanzol is the single active ingredient, lansoprazole, which is a racemic mixture designed for oral administration. A distinguishing feature of this medication is its presentation as a gastro-resistant capsule or delayed-release capsule. This specialized pharmaceutical preparation is vital because the enteric coating protects the lansoprazole compound from being destroyed by the corrosive stomach acid, ensuring the drug is released only in the small intestine for optimal absorption and function.


What is the General Purpose of its Action?

The general purpose of Lanzol's action is to achieve a profound and long-lasting reduction of gastric acid secretion. Lansoprazole specifically targets and blocks the proton pumps—the final mechanism of acid production—within the stomach's parietal cells. This consistent antisecretory action is the primary benefit, which serves to mitigate symptoms typically associated with acid irritation, such as frequent heartburn, and aids in supporting the natural healing of irritated or damaged digestive tissues by reducing the constant acid burden. The PPI class is characterized by its ability to achieve robust and reliable acid control.

Regulatory References

  1. Lansoprazole: MedlinePlus Drug Information

What side effects are possible with Lanzol?

The official safety profile for Lanzol (lansoprazole) is primarily categorized by the frequency of adverse reactions and specific risks associated with long-term use.

Adverse Reactions

The most common adverse reactions reported in clinical trials typically involve the gastrointestinal system and include diarrhea, abdominal pain, nausea, and headache. Reports of less frequent or post-marketing events have documented acute tubulointerstitial nephritis and severe cutaneous reactions like toxic epidermal necrolysis (TEN).

Serious and Long-Term Risks

Certain clinically significant risks are associated with the prolonged use (typically one year or longer) of this medicine. These include:

  • Bone Fracture: Long-term and/or high-dose therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine.
  • Hypomagnesemia: Low serum magnesium levels have been reported, often after one year of therapy, which can lead to serious events such as cardiac arrhythmias and seizures. Monitoring of magnesium levels may be considered for patients on long-term treatment.
  • C. difficile-associated Diarrhea: This medicine may be associated with an increased risk of severe diarrhea caused by Clostridioides difficile infection.
  • Vitamin B12 Deficiency: Daily, long-term use (e.g., longer than three years) may lead to malabsorption or a deficiency of Vitamin B12.
  • Fundic Gland Polyps: The risk of developing these benign growths in the stomach lining increases with long-term use, especially beyond one year.

Safety Restrictions and Specific Populations

Lanzol is contraindicated in patients with a known hypersensitivity to the drug or any other proton pump inhibitor (PPI). It is also contraindicated for use with products containing the HIV medication rilpivirine.

Use in children younger than one year of age is not recommended due to limited data and a reported risk of heart valve thickening in this specific age group. Caution is advised, and a dose adjustment may be necessary for patients with severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section is derived solely from official government regulatory documents.

Documented Overdose Profile

Official regulatory information indicates a lack of severe, unique toxicity following ingestion of excessive amounts of Lanzol (lansoprazole). In one documented case of acute overdosage, a patient reportedly ingested up to 600 mg of lansoprazole, which is substantially higher than the maximum recommended daily dose, and experienced no adverse effects or specific overdose symptoms.

Signs and Symptoms

No consistent or defining pattern of overdose manifestations, signs, or symptoms has been established in regulatory documents based on reported human cases. The drug is generally characterized by limited acute toxicity, even at very high doses.

Emergency Actions and Management

Immediate medical help must be sought or a Poison Control Center contacted immediately if an overdose of Lanzol is suspected or confirmed.

Treatment of an overdose is primarily symptomatic and supportive. There is no specific pharmacological antidote known for Lanzol. Furthermore, the official labeling states that Lanzol is not removed from the circulation by hemodialysis, meaning this procedure is not effective for overdose management.

Therapeutic Uses of Lanzol

What Lanzol Treats: Main Uses and Benefits

Lanzol is commonly used to provide symptomatic support for conditions driven by the chronic, upward flow of stomach acid, including Gastroesophageal Reflux Disease (GERD) and Erosive Esophagitis. Used in situations involving certain distressing symptoms, consistent with its therapeutic classification, it is applied when symptoms such as frequent heartburn and acid regurgitation create noticeable interference with daily stability. Used in areas where short-term symptom management is appropriate, the medication is considered relevant for a range of conditions. The primary indications where Lanzol is commonly used include support for conditions involving active duodenal or gastric ulcers, the management of pathological hypersecretion (e.g., Zollinger-Ellison Syndrome), and as a key component in combination regimens applied to manage H. pylori infection. It may assist with managing the risk of recurrence in chronic acid conditions and ulcers associated with Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This support helps ease the overall symptom load and contributes to improved day-to-day comfort.

QuickFact Block

Property Description
Primary Therapeutic Goal Symptomatic support for acid-related disorders.
Key Symptom Axes Symptoms related to inflammatory or irritative states (heartburn, acid pain).
Core Indications Covered GERD, Erosive Esophagitis, Peptic Ulcers, H. pylori, and Pathological Hypersecretion.
Clinical Scenarios Acute healing phases and long-term maintenance therapy.
Patient Benefit Helps ease the overall symptom load and assists with maintaining functional stability.

Eligibility and Restrictions for Use

Eligibility and Contraindications

Official regulatory documents establish clear populations for whom the use of lansoprazole (Lanzol) is either permitted or strictly prohibited.

Eligibility Status Population/Condition Regulatory Context
Contraindicated Patients with known severe hypersensitivity or allergy to lansoprazole or any component of the formulation. Strict prohibition.
Contraindicated Patients receiving rilpivirine-containing products (due to a drug-drug interaction). Strict prohibition.
Not Recommended Pediatric patients less than one year of age. Safety and effectiveness not established; risk of adverse effects in nonclinical studies.
Not Recommended Concomitant use with certain HIV protease inhibitors (e.g., atazanavir, nelfinavir). Leads to significantly reduced drug absorption and therapeutic effect of the HIV medication.
Use with Caution Patients with moderate to severe hepatic impairment. Dose adjustment (e.g., 50% reduction) and regular supervision are officially recommended due to altered drug clearance.

For pediatric use, safety and efficacy are typically established for children one year of age and older. Use during pregnancy and lactation is generally subject to an official recommendation to use only if the potential benefit justifies the potential risk, as human data are limited and presence in breast milk is not fully known. Certain formulations, such as the orally disintegrating tablet (ODT), are also restricted for use in patients with phenylketonuria (PKU) because they contain phenylalanine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lanzol (Lansoprazole) can alter the effectiveness or increase the concentration of other substances through documented mechanisms primarily related to elevating gastric pH and interacting with hepatic enzyme systems.

Pharmacokinetic and pH-Dependent Interactions

Lanzol significantly reduces the absorption and exposure of certain antivirals (e.g., Rilpivirine) and some antifungals (e.g., Ketoconazole) whose bioavailability relies on an acidic stomach environment. Concomitant use with Rilpivirine is generally restricted.

Lansoprazole is metabolized by the CYP2C19 and CYP3A4 enzymes. Therefore, strong enzyme inducers (e.g., Rifampicin, St. John's wort) can reduce Lanzol's plasma concentration, while Fluvoxamine (a CYP2C19 inhibitor) can increase its levels.

Other Significant Documented Interactions

Substance / Class Interaction Effect
Clopidogrel May reduce the therapeutic effect of the antiplatelet medicine.
Tacrolimus Plasma concentrations can be increased; requires careful monitoring.
Digoxin Plasma levels may be elevated.
Methotrexate High-dose co-administration may prolong Methotrexate concentrations, requiring consideration for temporary withdrawal.

Timing Constraints: Sucralfate and antacids can reduce the absorption of Lanzol. It is necessary to separate the administration of these agents by at least one hour.

Mechanism of Action

How Lanzol Works: The Mechanism of Action

Lanzol's action is defined by a precise, two-step antisecretory mechanism that targets the final stage of acid production in the stomach. The result is a sustained reduction in gastric acidity.

Irreversible Blockade of the Proton Pump

This domain centers on the H^+, K^+-ATPase enzyme, the molecular machine responsible for pumping acid (hydrogen ions) into the stomach lumen. The drug's active form achieves irreversible inhibition by forming a covalent bond with specific cysteine residues on the enzyme's structure. This binding functionally and permanently inactivates the pumps, halting the transport of H^+ ions. This mechanism results in the cessation of hydrogen ion efflux, leading to a prolonged shift in intragastric pH.

Acid-Dependent Activation and Action Duration

Lansoprazole operates as a prodrug that requires activation by the highly acidic environment within the parietal cells' secretory canaliculi. This localized pH-dependent conversion traps the active compound exactly where it is needed, enhancing its specificity. The irreversible nature of the blockade ensures that acid secretion can only resume when the cell synthesizes new proton pumps to replace the damaged ones, which is a slow biological process. This cell-renewal dependency governs the duration of the functional acid-blocking effect.

Dosage and Administration Information

How Lanzol is Used: Official Dosing and Administration

Lanzol (lansoprazole) is an oral medication, typically available as a 15 mg or 30 mg gastro-resistant capsule or delayed-release tablet. The official instructions for use emphasize timing and administration technique to ensure the drug, which is acid-sensitive, is properly absorbed.


Administration Protocol and Timing

Lanzol must be administered once daily, and for optimal effect, it should be taken before eating. In most cases, this means taking the dose in the morning, 30 minutes prior to a meal. For specific regimens, such as those used for H. pylori eradication, the official schedule is twice daily (e.g., morning and evening).


Official Dosing and Course Duration

Doses and treatment length are defined by the condition being managed. Most acute uses, such as active ulcers or Erosive Esophagitis, require short-term courses typically lasting 4 to 8 weeks. In contrast, maintenance therapy and treatment for Pathological Hypersecretory Conditions (like ZES) may require continuous, long-term use under supervision, with individually adjusted dosages. The standard doses are 15 mg or 30 mg daily, while doses over 120 mg/day for ZES must be administered in divided doses.


Key Usage Requirements

Requirement Official Instruction Population Notes
Swallowing The capsule must be swallowed whole and not crushed or chewed. Geriatric patients should generally not exceed 30 mg daily.
Alternative Use If the capsule cannot be swallowed whole, the intact pellets may be mixed with a small amount of specific soft food (e.g., applesauce) or juice (e.g., apple, tomato) and swallowed immediately. A 50% dose reduction is recommended for patients with moderate to severe hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lanzol

This overview summarizes the types of studies that have been conducted on Lansoprazole and the general findings reported in scientific literature, focusing on the research context without offering clinical advice or making claims about personal outcomes.


Evidence for Healing Erosive Esophagitis and Symptom Management in GERD

The research supporting the use of Lansoprazole for Gastroesophageal Reflux Disease (GERD) and Erosive Esophagitis (EE) is primarily based on Randomized Controlled Trials (RCTs). These short-term studies were designed to explore how the healing of the esophageal lining and patient-reported outcomes were related to the use of the study drug, particularly outcomes related to physical discomfort, such as heartburn and acid regurgitation.

Research explored outcomes in cohorts receiving Lansoprazole versus groups receiving placebo. Findings described patterns in measurements of tissue integrity and how symptoms evolved in the observed populations. Research also explored its use in sustained follow-up phases after tissue healing was achieved, particularly in research contexts involving fluctuating or unstable symptoms where EE might otherwise recur.

What remains uncertain: Subgroup findings are uncertain for the most severe forms of EE (higher grades of injury) in adolescents. Also, evidence quality varies across studies when it comes to complete, 24-hour symptom control for all patient profiles.


Research Supporting Peptic Ulcer Healing

Lansoprazole was studied for its evaluation in conditions characterized by inflammatory or irritative states such as active Duodenal and Gastric Ulcers. Research for this indication relied on short-term RCTs that measured patterns in ulcer integrity by using endoscopic confirmation.

Research examined the compound both alone and as a component in multi-drug regimens studied in conditions associated with the H. pylori bacteria. Findings describe patterns observed in the studies where the use of Lansoprazole was associated with measurements suggesting higher rates of ulcer healing compared to older medication classes. Limited information for long-term outcomes is available regarding the durability of maintained ulcer integrity after the initial treatment or maintenance phase has concluded.


Evidence in Pediatric and Other Special Populations

Studies were observed in specific patient groups including adolescents (age 12–17 years) and younger children with GERD and EE. These trials focused on outcomes capturing phases of heightened symptom activity and the resolution of symptoms. Evidence suggests patterns similar to those observed for milder forms; however, certainty remains low for the most severe cases in this younger age group due to insufficient data.


What is Still Uncertain About the Research for Lanzol

Long-term research on outcomes has largely relied on observational data, not the same high-quality, large-scale, placebo-controlled RCTs that characterized the short-term phase. Comparative evidence is lacking for some outcomes, as studies may not have directly compared Lansoprazole to the entire range of newer acid-suppressing agents on the market. Finally, the results apply only to the populations studied, meaning findings from large adult RCTs may not directly translate to all special populations. Research is ongoing to address these uncertainties.

Key Studies & References

  1. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Frequently Asked Questions (FAQ)

Common questions about Lanzol (FAQ)

Q: How quickly does Lanzol start working for acid reflux?

A: Official product information indicates that Lanzol is not designed for immediate symptom relief. While some individuals may notice complete relief of symptoms within 24 hours, the product often requires consistent use for 1 to 4 days to achieve its full acid-blocking effect.


Q: What happens if I forget to take a dose of Lanzol?

A: General instructions described in product information suggest taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, it is generally advised that the missed dose be skipped. Official principles state that two doses should never be taken at the same time to compensate for a missed dose.


Q: Is it normal to feel a bit nauseous after starting Lanzol?

A: Nausea is reported in official clinical trial data as one of the commonly observed adverse events associated with Lanzol. This means it has been frequently observed in study populations.


Q: Are headaches a common side effect of Lanzol?

A: Official reports indicate that headache is one of the most frequently observed adverse events in study populations. It is listed in regulatory information as a common adverse reaction associated with the use of Lanzol.


Q: Does Lanzol cause diarrhea in many people?

A: Diarrhea is consistently reported in official sources and studies. It is frequently observed in clinical studies as a common adverse event associated with the use of this medication.


Q: Are there any reports about Lanzol causing difficulty sleeping?

A: Reports of insomnia, which is difficulty sleeping, have been documented as a less common side effect in official adverse event listings for Lanzol.


Q: Is Lanzol known to affect the absorption of certain nutrients?

A: Official warnings state that long-term daily use of Lanzol (typically over three years) may be associated with reduced absorption and potential deficiency of Vitamin B12. Additionally, prolonged use has been linked to cases of low serum magnesium, or Hypomagnesemia.


Q: Does Lanzol affect my ability to drive or operate machinery?

A: Regulatory guidance advises caution before driving or operating machinery until the individual is aware of how the medicine affects them, as dizziness has been reported. This is because Lanzol may cause dizziness in some people.


Q: What are the official sources saying about using Lanzol while breastfeeding?

A: Official guidance notes that the use of this medicine requires consultation with a healthcare professional if pregnant or breastfeeding, as human data are limited. However, some authoritative databases note that the medicine has been safely used in infants, suggesting harm is considered unlikely.


Q: Are there documented cases of allergic reactions to Lanzol?

A: Official warnings include the potential for severe skin reactions, such as skin reddening, rash, and blistering. The medicine is contraindicated for individuals with a known hypersensitivity or allergy to the drug or its components.


Q: Does Lanzol have a risk of rebound acid production when stopped?

A: Some medical reviews and consumer groups have raised concerns about the potential for 'rebound' acid hypersecretion (overproduction) when Proton Pump Inhibitors ( PPIs) like Lanzol are discontinued. Official labeling emphasizes that the lowest effective dose for the shortest duration necessary should be used.


Q: Can Lanzol affect the results of a stomach bacteria test?

A: Official guidance notes that Lanzol can interfere with the accuracy of diagnostic tests for extitHelicobacter pylori (like the urea breath test). This may lead to false-negative results. Because of this potential interference, testing is generally recommended to be performed after discontinuing the medicine for a specified period.


Q: What research is available on Lanzol for stomach protection?

A: Regulatory documents include an official indication for using Lanzol for the prevention (prophylaxis) of gastric and duodenal ulcers. This use is specifically for at-risk patients requiring long-term use of certain pain relievers classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).


Q: Does taking Lanzol mean I might need other tests?

A: Official information indicates that for patients on long-term treatment, monitoring of serum magnesium levels may be necessary. Additionally, a healthcare professional may consider further diagnostic testing for adults who are not responding optimally to the treatment.


Q: Does Lanzol have an age limit for use in younger adults?

A: Official product information supports the use of Lanzol for certain indications in pediatric patients 12 to 17 years of age. This covers the adolescent period leading up to young adulthood, though it is not recommended for children under one year old.


Q: What are the common reasons a doctor might prescribe Lanzol?

A: Lanzol is officially indicated for several acid-related conditions, including the short-term treatment of Erosive Esophagitis (severe irritation of the esophagus) and symptomatic GERD. It is also used for healing ulcers and managing extreme acid overproduction like Zollinger-Ellison Syndrome.


Q: Is there a list of specific medicines that absolutely cannot be taken with Lanzol?

A: Yes, Lanzol is strictly contraindicated for use with products that contain the HIV medication rilpivirine. Official guidance also advises against co-use with other HIV protease inhibitors, such as atazanavir, due to a significant reduction in the effectiveness of the HIV medication.


Q: Is the onset of action different for the various Lanzol forms?

A: Official documentation mentions various forms of Lanzol (e.g., capsules, orally disintegrating tablets). All of these are designed as enteric-coated preparations for absorption in the intestine. The official timeframe for the onset of symptom relief (1 to 4 days) applies to the active drug, regardless of the specific form used.


Q: Can Lanzol be used to manage persistent cough caused by reflux?

A: Lanzol is officially indicated for the treatment of Symptomatic GERD. Since a chronic cough can sometimes be a symptom of GERD, the medicine may be used to treat the underlying acid-related cause. However, official indications do not list chronic cough as a primary condition for treatment.


Q: What are the official warnings about stopping Lanzol suddenly?

A: The official label emphasizes using the medicine at the lowest dose for the shortest duration. Concerns have been noted regarding the potential for symptom return or rebound upon abrupt discontinuation. This is why use is generally monitored by a professional.


Q: Is Lanzol safe for older adults to take?

A: Dose adjustment is typically not required for older adults. However, a maximum daily dosage of mathbf30 mg is generally recommended, and official warnings note an association between long-term, high-dose use and an increased risk of bone fractures, particularly in older patients.


Q: What kind of stomach issues does Lanzol help with?

A: Lanzol is officially indicated for several acid-related conditions, including the short-term treatment of GERD and Erosive Esophagitis, healing stomach and duodenal ulcers, and managing conditions of extreme acid overproduction like Zollinger-Ellison Syndrome.


Q: Is Lanzol the same as other medicines for heartburn?

A: Lanzol belongs to a specific class of drugs called Proton Pump Inhibitors ( PPIs), which act by permanently blocking the final step of acid secretion. This is a different method of action compared to antacids (which neutralize existing acid) or H2 blockers (which reduce acid production via histamine receptors).


Q: Can Lanzol interact with common vitamins or supplements?

A: Official product information warns of a potential interaction with the supplement St. John’s wort. Additionally, long-term use can affect the body's levels of Vitamin B12 and magnesium, which may require monitoring.


Q: Can Lanzol be taken with pain relievers like ibuprofen?

A: Lanzol has an official indication for preventing ulcers associated with the necessary long-term use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen in at-risk patients. However, official information indicates that consultation with a professional is necessary before taking Lanzol concurrently with NSAIDs.


Q: Can Lanzol be used to prevent acid reflux at night?

A: Lanzol is generally administered once daily in the morning to achieve optimal acid control throughout the day. However, for certain indications (like extitH. pylori eradication), a twice-daily regimen is required, which includes an evening dose to maintain continuous acid suppression.


Q: Is the side effect profile of Lanzol similar to other Proton Pump Inhibitors?

A: As a class, Proton Pump Inhibitors ( PPIs) share similar official warnings concerning risks such as bone fracture and extitC. difficile infection. However, some studies have described variations in the rates of specific common adverse events among different PPIs.


Q: Is it okay to crush or chew the Lanzol capsule?

A: Official instructions strictly state that the capsule must be swallowed whole and should not be crushed or chewed, as the medication is protected by an enteric coating. If the capsule cannot be swallowed whole, the intact pellets inside can be mixed with specific soft foods (like applesauce) or juices and swallowed immediately.


Q: Is it required to take Lanzol at the exact same time every day?

A: Official instructions emphasize taking the medicine once daily and mathbf30 minutes before a meal, typically in the morning. This is an emphasis on the relationship to food and the daily frequency, rather than mandating an exact time of day for the dose.


Q: What is the recommended period for using Lanzol according to official guidelines?

A: For treating acute conditions, short-term courses are typically recommended, ranging from 2 to 8 weeks, depending on the specific diagnosis. For chronic conditions like Zollinger-Ellison Syndrome or certain maintenance therapies, use can be continuous but must remain under professional supervision.

How should Lanzol be stored and disposed of?

The storage and disposal of Lanzol (lansoprazole delayed-release capsules) must strictly adhere to regulatory requirements to preserve the drug's stability.

Official Storage Conditions

Requirement Regulatory Statement
Temperature Store at controlled room temperature (20 C to 25 C) and not above 25 C.
Protection Must be protected from moisture and heat.
Container Store in the original package and keep tightly closed.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal

The product must be used within three months after first opening the container (for bottle presentations). The official instructions for disposal mandate that expired or unused product must be discarded according to local regulations and not disposed of via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lanzol found in:

A-Z Index: